Ditchcarbon
  • Customers
  1. Organizations
  2. Zhejiang Huahai
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 5 months ago

Zhejiang Huahai

Company website

Zhejiang Huahai Pharmaceutical Co., Ltd., commonly referred to as Huahai, is a prominent player in the global pharmaceutical industry, headquartered in Zhejiang, China. Founded in 1989, the company has established itself as a leader in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, particularly in the fields of cardiovascular and anti-infective medications. With a strong presence in both domestic and international markets, Huahai operates in various regions, including North America, Europe, and Asia. The company is renowned for its commitment to quality and innovation, boasting a diverse portfolio of products that meet stringent regulatory standards. Notable achievements include multiple certifications from global health authorities, positioning Huahai as a trusted supplier in the pharmaceutical sector.

DitchCarbon Score

How does Zhejiang Huahai's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Zhejiang Huahai's score of 27 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

36%

Let us know if this data was useful to you

Zhejiang Huahai's reported carbon emissions

Zhejiang Huahai Pharmaceutical Co., Ltd., headquartered in China, has set ambitious climate commitments aimed at significantly reducing its greenhouse gas emissions. Although specific emissions data for the most recent year is not available, the company has established near-term targets through the Science Based Targets initiative (SBTi). Zhejiang Huahai commits to reducing its absolute Scope 1 and Scope 2 greenhouse gas emissions by approximately 42% by 2030, using 2023 as the base year. Additionally, the company aims to decrease its Scope 3 emissions by about 51.6% per million CNY value added by 2030, with a 2022 base year. These targets align with the necessary reductions to limit global warming to 1.5°C, reflecting the company's commitment to sustainable practices within the pharmaceuticals, biotechnology, and life sciences sector. As of now, Zhejiang Huahai has not reported any absolute emissions figures, but its proactive stance on emissions reduction demonstrates a commitment to addressing climate change and enhancing environmental sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zhejiang Huahai's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Zhejiang Huahai is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zhejiang Huahai is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Upjohn Inc.

US
•
Financial intermediation services, except insurance and pension funding services (65)
Updated 14 days ago

Tianyu Pharmaceutical

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Hisun Pharmaceutical

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Jubilant Pharma Limited

SG
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Cr Pharmaceutical

HK
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.9
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy